For Users
—
Our DNA methylation blood test, meeting LDT standards, offers an efficient and accurate solution for cancer detection.
It integrates easily into healthcare systems for screening, monitoring, and surveillance, improving clinical workflow and health management.
Technological Innovation for Clinical Applications
DNA methylation blood testing offers an efficient and accurate tool for cancer screening and health monitoring.
It helps physicians assess cancer risk and track treatment effectiveness, playing a key role in monitoring progress and changes in the patient’s condition.
Easy Integration, Compliant with LDT Standards
Our DNA methylation blood testing technology complies with LDT (Laboratory Developed Tests) standards and ISO 15189:2012, offering high-quality and reliable testing services that can be seamlessly integrated into existing healthcare systems, making it suitable for various medical institutions.
Using Real-time Polymerase Chain Reaction (Real-time PCR) technology, it offers high sensitivity and accuracy, reducing human error and increasing efficiency. The test results provide physicians with reliable data to accurately track genetic changes, enabling personalized treatment plans. This optimizes clinical workflows and supports more efficient decision-making in patient care, improving cancer detection and health management.
Using real-time PCR technology, our test accurately detects small genetic changes, providing reliable results. Following international standards, it delivers efficient, safe, and trustworthy testing services, adding significant value for healthcare institutions and patients.
Flexible Application for Various Needs
This technology can be used to track treatment outcomes, monitor tumor progression or recurrence, and provide clinical validation data to assist healthcare institutions in decision-making during cancer detection and health monitoring, helping to better manage patient health.
